Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

[Prognostic factors for patients with brain metastases].

Le Scodan R, Massard C, Noël G.

Bull Cancer. 2013 Jan 1;100(1):45-50. doi: 10.1684/bdc.2012.1679. Review. French.

2.

[Brain metastases from breast cancer: usefulness and limits of prognostic scores].

Le Scodan R, Massard C, Jouanneau L, Gutierrez M, Mouret-Fourme E.

Bull Cancer. 2011 Apr;98(4):377-84. doi: 10.1684/bdc.2011.1344. Review. French.

3.

Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.

Viani GA, Castilho MS, Salvajoli JV, Pellizzon AC, Novaes PE, Guimarães FS, Conte MA, Fogaroli RC.

BMC Cancer. 2007 Mar 26;7:53.

4.

Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.

Caballero JA, Sneed PK, Lamborn KR, Ma L, Denduluri S, Nakamura JL, Barani IJ, McDermott MW.

Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):303-9. doi: 10.1016/j.ijrobp.2011.06.1987. Epub 2011 Nov 11.

PMID:
22079723
5.

Brain metastases from breast carcinoma: validation of the radiation therapy oncology group recursive partitioning analysis classification and proposition of a new prognostic score.

Le Scodan R, Massard C, Mouret-Fourme E, Guinebretierre JM, Cohen-Solal C, De Lalande B, Moisson P, Breton-Callu C, Gardner M, Goupil A, Renody N, Floiras JL, Labib A.

Int J Radiat Oncol Biol Phys. 2007 Nov 1;69(3):839-45. Epub 2007 Jun 4.

PMID:
17544592
6.

Stereotactic radiosurgery for patients with brain metastases from small cell lung cancer.

Wegner RE, Olson AC, Kondziolka D, Niranjan A, Lundsford LD, Flickinger JC.

Int J Radiat Oncol Biol Phys. 2011 Nov 1;81(3):e21-7. doi: 10.1016/j.ijrobp.2011.01.001. Epub 2011 Feb 23.

PMID:
21345622
7.

Radiotherapeutic management of brain metastases: a systematic review and meta-analysis.

Tsao MN, Lloyd NS, Wong RK, Rakovitch E, Chow E, Laperriere N; Supportive Care Guidelines Group of Cancer Care Ontario's Program in Evidence-based Care.

Cancer Treat Rev. 2005 Jun;31(4):256-73. Review.

PMID:
15951117
8.

Whole brain radiotherapy for the treatment of multiple brain metastases.

Tsao MN, Lloyd N, Wong R, Chow E, Rakovitch E, Laperriere N.

Cochrane Database Syst Rev. 2006 Jul 19;(3):CD003869. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD003869.

PMID:
16856022
9.
10.

Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.

Antoni D, Clavier JB, Pop M, Schumacher C, Lefebvre F, Noël G.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):630-7. doi: 10.1016/j.ijrobp.2013.02.027. Epub 2013 Apr 11.

PMID:
23582409
11.

Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.

Rades D, Bohlen G, Dunst J, Lohynska R, Veninga T, Stalpers L, Schild SE, Dahm-Daphi J.

Strahlenther Onkol. 2008 Jan;184(1):30-5. doi: 10.1007/s00066-008-1795-5.

PMID:
18188520
12.

Whole brain radiation therapy (WBRT) alone versus WBRT and radiosurgery for the treatment of brain metastases.

Patil CG, Pricola K, Garg SK, Bryant A, Black KL.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD006121. doi: 10.1002/14651858.CD006121.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;9:CD006121.

PMID:
20556764
13.

Prognostic factors for patients with microsurgically resected brain metastases.

Korinth MC, Delonge C, Hütter BO, Gilsbach JM.

Onkologie. 2002 Oct;25(5):420-5.

PMID:
12415195
14.

Results of whole brain radiotherapy in patients with brain metastases from breast cancer: a retrospective study.

Mahmoud-Ahmed AS, Suh JH, Lee SY, Crownover RL, Barnett GH.

Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):810-7.

PMID:
12377333
15.

Whole-brain radiotherapy with 20 Gy in 5 fractions for brain metastases in patients with cancer of unknown primary (CUP).

Rades D, Bohlen G, Lohynska R, Veninga T, Stalpers LJ, Schild SE, Dunst J.

Strahlenther Onkol. 2007 Nov;183(11):631-6.

PMID:
17960339
16.

Prognostic factors affecting the outcome of brain metastases from breast cancer.

Liu MT, Hsieh CY, Wang AY, Chang TH, Pi CP, Huang CC, Huang CY, Liou CH.

Support Care Cancer. 2006 Sep;14(9):936-42. Epub 2006 Mar 31.

PMID:
16575571
17.

Prognosis of patients treated for intracranial metastases with whole-brain irradiation.

Sundström JT, Minn H, Lertola KK, Nordman E.

Ann Med. 1998 Jun;30(3):296-9.

PMID:
9677016
18.

A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.

Rades D, Dunst J, Schild SE.

Strahlenther Onkol. 2008 May;184(5):251-5. doi: 10.1007/s00066-008-1831-5.

PMID:
18427755
19.

Dose escalation in patients receiving whole-brain radiotherapy for brain metastases from colorectal cancer.

Heisterkamp C, Haatanen T, Schild SE, Rades D.

Strahlenther Onkol. 2010 Feb;186(2):70-5. doi: 10.1007/s00066-010-2067-8. Epub 2010 Jan 26.

PMID:
20127223
20.

The role of whole brain radiation therapy in the management of melanoma brain metastases.

Dyer MA, Arvold ND, Chen YH, Pinnell NE, Mitin T, Lee EQ, Hodi FS, Ibrahim N, Weiss SE, Kelly PJ, Floyd SR, Mahadevan A, Alexander BM.

Radiat Oncol. 2014 Jun 22;9:143. doi: 10.1186/1748-717X-9-143.

Supplemental Content

Support Center